Both are rapid-onset, short-duration GH secretagogues
You should see a drop of medication appear at the needle tip, confirming that air has been expelled
GLP-1 class safety monitoring should include awareness of these important risks: Pancreatitis : Patients should promptly report severe abdominal pain, with or without vomiting Gallbladder disease : Report symptoms of biliary colic or cholecystitis Acute kidney injury : Maintain adequate hydration, especially if experiencing nausea/vomiting Hypoglycemia : Increased risk when used with insulin or sulfonylureas Suicidal ideation : For patients using Wegovy or Zepbound, monitor for mood changes Patients should be counseled to report any neck swelling, difficulty swallowing, persistent hoarseness, or palpable thyroid nodules, as these warrant evaluation regardless of GLP-1 use
#1 Discuss the Risks of Fraudulent Weight Loss Medications Due to the insatiable demand for weight loss and the proven fat-shredding powers of GLP-1 RAs, scams and counterfeit drugs flood the marketing
Protecting your muscle is vital for maintaining a healthy metabolism
Discontinue promptly if suspected and avoid re-exposure to exenatide Serious Injection-Site Reactions (eg, abscess, cellulitis, and necrosis), with or without subcutaneous nodules, have been reported Acute Gallbladder Disease has been reported in GLP-1 receptor agonist trials, including exenatide
